EUVIMEDEUVIMED entdecken
Crossref

K 2 FeO 4 ‐Enhanced Photodynamic Therapy of Breast Cancer via In Situ Synthesis of Fe 2 O 3 and O 2

Yi Sun, Xin Peng, Yudong Guan, Tong Su, Zezun Xie, Ziying Wu, Yongxuan Long, Huihui Zhu, Jie Shao, Xiaoli Mai, Xuzhi Shi, Tingting Wu und 4 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202402827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yi Sun und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, Jiangsu, …. Hauptthemen laut MEDLINE: Photochemotherapy, Breast Neoplasms, Ferric Compounds, Oxygen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Nanjing Health Science and Technology Development Special Fund Major Project, Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University, the Shenzhen Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic Therapy (PDT) offers a promising minimally invasive treatment for breast cancer, but its efficacy is limited by the hostile tumor microenvironment (TME), including hypoxia and high glutathione (GSH) levels. Although various strategies to improve oxygen concentration or reduce reactive oxygen species (ROS) resistance for enhanced PDT have been explored, they typically require intricate design and complex synthesis of multifunctional nanocarriers. Thus, this study introduces a facile K 2 FeO 4 ‐induced strategy to enhance PDT efficiency in breast cancer through the tumor in situ synthesis of Fe 2 O 3 and O 2 . Inspired by the successful application of K 2 FeO 4 in ecological remediation and hemostasis, K 2 FeO 4 reacts with GSH, biological system, H 2 O 2 , and water, to generate Fe 2 O 3 and O 2 . Intratumoral injection of K 2 FeO 4 improves the TME, followed by Ce6 administration to enhance PDT through synergistic ferroptosis. This approach boosts PDT efficacy significantly by increasing ROS generation, lipid peroxidation, and inhibiting GSH and GPX4. Proteomic analysis revealed alterations in key pathways, including endocytosis and energy metabolism. This K 2 FeO 4 ‐PDT strategy creates a positive feedback loop by enhancing oxidative stress, providing an interesting and promising approach to PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyBreast NeoplasmsFerric CompoundsOxygenFemaleHumansAnimalsReactive Oxygen SpeciesMiceTumor MicroenvironmentCell Line, TumorGlutathioneFerroptosisPhotosensitizing Agents

Stichwörter der Autor:innen

ferroptosisiron oxidephotodynamic therapypotassium ferrate (VI)

Substanzen

Ferric CompoundsReactive Oxygen SpeciesGlutathioneferric oxideOxygenPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, Jiangsu, 210023, China.
  • Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 22 Hankou Road, Nanjing, Jiangsu, 210008, China.
  • School of Stomatology, Henan University, Kaifeng, Henan, 475000, China.
  • Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
  • Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, Jiangsu, 210023, China.
  • Key Laboratory for Organic Electronics and Information Displays, Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials, Jiangsu National Synergetic Innovation Centre for Advanced Materials, Nanjing Univ…

ORCID-Profile: Kun Chen

Förderung

  • Nanjing Health Science and Technology Development Special Fund Major Project
  • Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University
  • the Shenzhen Science and Technology Program
  • the National Natural Science Foundation of China
  • a key project grant by the Medical Science and Technology Development Foundation, Nanjing Department of Health

Zitieren

APA

Sun, Y., Peng, X., Guan, Y., Su, T., Xie, Z., Wu, Z., Long, Y., Zhu, H., Shao, J., Mai, X., Shi, X., Wu, T., Teng, Z., Zhang, B., Chen, K., & Xin, X. (2025). K 2 FeO 4 ‐Enhanced Photodynamic Therapy of Breast Cancer via In Situ Synthesis of Fe 2 O 3 and O 2. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402827

Vancouver

Sun Y, Peng X, Guan Y, Su T, Xie Z, Wu Z, et al. K 2 FeO 4 ‐Enhanced Photodynamic Therapy of Breast Cancer via In Situ Synthesis of Fe 2 O 3 and O 2. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402827

BibTeX
@article{Sun2025,
  author = {Sun, Yi and Peng, Xin and Guan, Yudong and Su, Tong and Xie, Zezun and Wu, Ziying and Long, Yongxuan and Zhu, Huihui and Shao, Jie and Mai, Xiaoli and Shi, Xuzhi and Wu, Tingting and Teng, Zhaogang and Zhang, Bing and Chen, Kun and Xin, Xiaoyan},
  title = {K 2 FeO 4 ‐Enhanced Photodynamic Therapy of Breast Cancer via In Situ Synthesis of Fe 2 O 3 and O 2},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202402827}
}
Kostenlos starten →